Sale!

Hepatocellular Carcinoma HCC Panel Test

940 د.إ

-10%

The Hepatocellular Carcinoma (HCC) Panel Test is a specialized diagnostic tool designed to assist in the early detection and management of hepatocellular carcinoma, which is the most common type of liver cancer. Offered at DNA Labs UAE, this comprehensive test is priced at 940 AED. It employs cutting-edge genetic and molecular techniques to analyze specific biomarkers associated with HCC. By evaluating these markers, the test can provide valuable insights into the presence, progression, and characteristics of the tumor, facilitating personalized treatment strategies. The HCC Panel Test is a critical step for individuals at risk of developing liver cancer, offering a proactive approach to healthcare management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HEPATOCELLULAR CARCINOMA HCC PANEL Test

Test Cost: AED 940.0

Symptoms and Diagnosis:

The HEPATOCELLULAR CARCINOMA (HCC) PANEL test is a diagnostic tool used to detect and monitor hepatocellular carcinoma, which is the most common type of liver cancer. This panel test includes various blood markers and imaging techniques to assess the presence and progression of HCC.

The HCC panel typically includes the following tests:

  1. Alpha-fetoprotein (AFP) test: AFP is a protein that is often elevated in individuals with HCC. This test measures the levels of AFP in the blood and can be used to screen for HCC and monitor treatment response.
  2. Liver function tests: These tests measure the levels of liver enzymes, such as alanine transaminase (ALT) and aspartate transaminase (AST), which can be elevated in individuals with liver cancer.
  3. Imaging tests: Imaging techniques like ultrasound, computed tomography (CT) scan, and magnetic resonance imaging (MRI) can be used to visualize the liver and detect the presence of tumors or other abnormalities.
  4. Liver biopsy: In some cases, a liver biopsy may be performed to confirm the diagnosis of HCC. During this procedure, a small sample of liver tissue is removed and examined under a microscope.

The HCC panel test is often used in individuals at high risk for developing liver cancer, such as those with chronic hepatitis B or C infection, cirrhosis, or a family history of HCC. It helps in early detection, staging, and monitoring the progression of HCC, allowing for timely intervention and treatment.

Test Components:

  • CBC
  • AST (SGOT)
  • ALT (SGPT)
  • AST:ALT ratio
  • GGTP
  • Bilirubin, Total, Direct & Indirect
  • Protein, Total
  • Albumin
  • A:G ratio
  • Alkaline Phosphatase
  • LDH
  • AFP
  • DCP/PIVKA II

Price: 940.0 AED

Sample Condition: 3 mL (2 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Hemolysed specimens are not acceptable.

Report Delivery: SampleMon by 9 am; Report Same day

Method: Spectrophotometry, Electrical Impedence, VCS, Chemiluminescent Immunoassay, IFCC

Test Type: Disorders of Liver

Doctor: Oncologist, Gastroenterologist

Test Department:

Pre Test Information: Give brief clinical history.

Test Name HEPATOCELLULAR CARCINOMA HCC PANEL Test
Components *CBC*AST (SGOT)*ALT (SGPT) *AST:ALT ratio*GGTP*Bilirubin, Total, Direct & Indirect*Protein,Total*Albumin *A:G ratio *Alkaline Phosphatase*LDH *AFP*DCP/PIVKA II
Price 940.0 AED
Sample Condition 3 mL (2 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Give brief clinical history. Hemolysed specimens are not acceptable.
Report Delivery SampleMon by 9 am; Report Same day
Method Spectrophotometry, Electrical Impedence, VCS, Chemiluminescent Immunoassay, IFCC
Test type Disorders of Liver
Doctor Oncologist, Gastroenterologist
Test Department:
Pre Test Information Give brief clinical history.
Test Details

The HEPATOCELLULAR CARCINOMA (HCC) PANEL test is a diagnostic tool used to detect and monitor hepatocellular carcinoma, which is the most common type of liver cancer. This panel test includes various blood markers and imaging techniques to assess the presence and progression of HCC.

The HCC panel typically includes the following tests:

1. Alpha-fetoprotein (AFP) test: AFP is a protein that is often elevated in individuals with HCC. This test measures the levels of AFP in the blood and can be used to screen for HCC and monitor treatment response.

2. Liver function tests: These tests measure the levels of liver enzymes, such as alanine transaminase (ALT) and aspartate transaminase (AST), which can be elevated in individuals with liver cancer.

3. Imaging tests: Imaging techniques like ultrasound, computed tomography (CT) scan, and magnetic resonance imaging (MRI) can be used to visualize the liver and detect the presence of tumors or other abnormalities.

4. Liver biopsy: In some cases, a liver biopsy may be performed to confirm the diagnosis of HCC. During this procedure, a small sample of liver tissue is removed and examined under a microscope.

The HCC panel test is often used in individuals at high risk for developing liver cancer, such as those with chronic hepatitis B or C infection, cirrhosis, or a family history of HCC. It helps in early detection, staging, and monitoring the progression of HCC, allowing for timely intervention and treatment.